Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats

Fig. 5

Effect of β-HPC on liver glycogen content in rats with NASH. A Liver glycogen in the control group: PAS-positive areas mainly in the cytoplasm of hepatocytes. B NASH groups. C Liver glycogen in the non-treated NASH group: PAS-positive cells were significantly increased throughout liver parenchyma. D Liver glycogen in NASH group treated with β-HPC: PAS-positive cells were observed in liver parenchyma. Liver glycogen was demonstrated by Periodic acid–Schiff (PAS) staining, dark areas indicate presence of glycogen (magnification 40X). Each bar represents the mean ± SD; experiments were performed in duplicate. *p < 0.05 compared to control group, #p < 0.05 compared to NASH group without treatment. All groups consisted of 5 animals

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us